Results 241 to 250 of about 203,030 (263)

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Lancet, The, 2020
Javier Cortes, David W Cescon, Hope S Rugo   +2 more
exaly  

Pellian sequences derived from Pythagorean triples

International Journal of Mathematical Education in Science and Technology, 1995
J. V. Leyendekkers, J. RYBAK
openaire   +1 more source

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Lancet, The, 2020
Kwok-Cheung Lung, Tom Wai-Hin Chung, Hoi-Ping Shum   +2 more
exaly  

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Nature Reviews Clinical Oncology, 2016
Eapm Working Group For Oncology Clinical Research, Justin M Balko, Luca Gianni   +2 more
exaly  

Triple‐Helical Recognition of RNA Using 2‐Aminopyridine‐Modified PNA at Physiologically Relevant Conditions

Angewandte Chemie - International Edition, 2012
Eriks Rozners
exaly  

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

Lancet, The, 2017
Carsten Denkert, Andrew N J Tutt
exaly  

5401632 Triple helix purification and sequencing

Biotechnology Advances, 1995
openaire   +2 more sources

Convergent triple sequences and statistical cluster points

2022
Mehmet Gürdal, Mualla Birgül Huban
openaire   +1 more source

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Lancet, The, 2020
Elizabeth A Mittendorf, Shigehira Saji, Kyung Hae Jung   +2 more
exaly  

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2017
Jørgen Vestbo, Alberto A Papi, Massimo Corradi   +2 more
exaly